$0.1985
0[0.00%]
Last update: 3:50PM Get Real Time Here
Provectus
(OTCQB:PVCT)Latest News for Provectus Stock (OTC:PVCT)
Provectus Stock (OTC: PVCT)
Categories: All
Tuesday, January 24, 2023
Tuesday, January 17, 2023
Tuesday, March 24, 2020
Wednesday, August 24, 2016
Tuesday, August 23, 2016
Monday, July 18, 2016
Thursday, July 14, 2016
Wednesday, July 13, 2016
Tuesday, July 12, 2016
Monday, June 13, 2016
Thursday, May 19, 2016
Friday, April 22, 2016
- Provectus Will Report Data on PV-10 in Combo Therapy, T-Cell Mediated Immunity at AACR MeetingBenzinga - Apr 22, 2016, 6:09AM
- UPDATE: Provectus Says Presentation Showed Treatment with IL PV-10 and Anti-PD-1 Antibody Results in a Delay in Tumor Growth and Enhanced T Cell Activation in the M05 Tumor ModelBenzinga - Apr 22, 2016, 6:09AM
- Provectus Biopharmaceuticals Reports Data On PV-10 in Combination Therapy and T Cell Mediated Immunity Presented at AACR Annual Meeting 2016Benzinga - Apr 22, 2016, 6:07AM
Wednesday, March 30, 2016
Wednesday, March 16, 2016
- Provectus Biopharmaceuticals Amends Protocol for Phase 3 Study of PV-10 in Treatment of Locally Advanced Cutaneous MelanomaBenzinga - Mar 16, 2016, 6:21AM
- Provectus Biopharmaceuticals Files Non-Timely 10KBenzinga - Mar 16, 2016, 6:17AM
- Provectus Announces Results of Internal Investigation of Audit CommitteeBenzinga - Mar 16, 2016, 6:03AM